Evercore ISI raised the firm’s price target on Iqvia (IQV) to $240 from $220 and keeps an Outperform rating on the shares as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- Iqvia price target raised to $200 from $185 at Barclays
- Early notable gainers among liquid option names on October 1st
- Private Markets: Dyna Robotics raises $120M from Nvidia, Amazon
- Lululemon downgraded, Dick’s Sporting upgraded: Wall Street’s top analyst calls
- Iqvia upgraded to Buy from Hold at Jefferies